NCT02576431 A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors Status COMPLETED Phase PHASE2
NCT02576002 Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension) Status COMPLETED Phase N/A
NCT02574715 An Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess as Their Contraceptive Method Status COMPLETED Phase N/A
NCT02571569 A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors Status COMPLETED Phase PHASE1
NCT02564718 Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates Status COMPLETED Phase PHASE1/PHASE2
NCT02562235 Riociguat in Children With Pulmonary Arterial Hypertension (PAH) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02561923 A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy Participants Status COMPLETED Phase PHASE1
NCT02559232 An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers Status COMPLETED Phase N/A
NCT02558465 Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE) Status COMPLETED Phase N/A
NCT02556203 Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes Status TERMINATED Phase PHASE3
NCT02555878 A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants Status COMPLETED Phase PHASE3
NCT02555059 Special Drug Use Investigation of Ciproxan Injection in Pediatrics Status COMPLETED Phase N/A
NCT02553889 A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis Status COMPLETED Phase PHASE2
NCT02550717 Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN) Status COMPLETED Phase N/A
NCT02549469 Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times Daily Status COMPLETED Phase PHASE1